Kristen Landon - Jan 17, 2025 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role
Chief Operating Officer
Signature
/s/ Kristen Landon
Stock symbol
SXTP
Transactions as of
Jan 17, 2025
Transactions value $
$0
Form type
4
Date filed
8/14/2025, 09:23 PM
Previous filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Landon Kristen Chief Operating Officer C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON /s/ Kristen Landon 2025-08-14 0002053910

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXTP Common Stock Award $0 +4.54K $0.00 4.54K Jan 17, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed late due to an inadvertent administrative error.
F2 The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.